https://www.theguardian.com/society/2025/may/31/neck-and-head-cancer-breakthrough-drug-immunotherapy
- Forums
- ASX - By Stock
- IMM
- Merck conundrum
IMM
immutep limited
Add to My Watchlist
4.00%
!
24.0¢

Merck conundrum, page-62
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $350.4M |
Open | High | Low | Value | Volume |
24.5¢ | 25.0¢ | 23.5¢ | $502.9K | 2.090M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 490422 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 71044 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 487938 | 0.235 |
22 | 1093281 | 0.230 |
11 | 286458 | 0.225 |
15 | 304469 | 0.220 |
1 | 150000 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 71044 | 6 |
0.245 | 111917 | 11 |
0.250 | 219473 | 13 |
0.255 | 205736 | 14 |
0.260 | 792776 | 9 |
Last trade - 14.10pm 18/06/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online